BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24406852)

  • 1. Recurrence of infantile hemangioma after termination of propranolol treatment.
    Chang L; Ma G; Jin Y; Ye X; Qiu Y; Chen H; Yu W; Yang X; Hu X; Lin X
    Ann Plast Surg; 2014 Feb; 72(2):173-5. PubMed ID: 24406852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe infantile haemangioma: complications and treatment.
    Heaton P; Kennedy C; Amin S
    J Paediatr Child Health; 2014 Apr; 50(4):325, 330. PubMed ID: 24698064
    [No Abstract]   [Full Text] [Related]  

  • 3. Propranolol for orbital hemangioma.
    Taban M; Goldberg RA
    Ophthalmology; 2010 Jan; 117(1):195-195.e4. PubMed ID: 20114117
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences].
    Léauté-Labrèze C; Taïeb A
    Ann Dermatol Venereol; 2008 Dec; 135(12):860-2. PubMed ID: 19084699
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
    Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
    Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary experiences in treating infantile hemangioma with propranolol.
    Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
    Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol Use for Infantile Hemangiomas.
    Ryan J
    Plast Surg Nurs; 2015; 35(3):129-30. PubMed ID: 26313676
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrence of infantile hemangiomas treated with propranolol.
    Bagazgoitia L; Hernández-Martín Á; Torrelo A
    Pediatr Dermatol; 2011; 28(6):658-662. PubMed ID: 22082463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol.
    Rotter A; Samorano LP; de Oliveira Labinas GH; Alvarenga JG; Rivitti-Machado MC; Bouer M; Santos PC; Silvestre DA; de Oliveira ZN
    Int J Dermatol; 2017 Feb; 56(2):190-194. PubMed ID: 27813086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol in the management of infantile hemangiomas: clinical response and predictors.
    Balma-Mena A; Chakkittakandiyil A; Weinstein M; Lansang P; Ho N; Cammisuli S; Pope E
    J Cutan Med Surg; 2012; 16(3):169-73. PubMed ID: 22713439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta blocker treatment for infantile hemangiomas.
    Rouhana HF; Fruge JH; Massengale WT
    Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile haemangiomas that failed treatment with propranolol: clinical and histopathological features.
    Phillips RJ; Lokmic Z; Crock CM; Penington A
    J Paediatr Child Health; 2014 Aug; 50(8):619-25. PubMed ID: 24905852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of β2-adrenoceptors are expressed in infantile capillary hemangiomas and may mediate the therapeutic effect of propranolol.
    Hadaschik E; Scheiba N; Engstner M; Flux K
    J Cutan Pathol; 2012 Sep; 39(9):881-3. PubMed ID: 22764832
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas.
    Tang YJ; Zhang ZZ; Chen SQ; Chen SM; Li CJ; Chen JW; Yuan B; Xia Y; Wang L
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):759-762. PubMed ID: 26489635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple pulmonary infantile hemangiomas responsive to oral propranolol.
    Galdeano F; Herón A; Moreno S; Aprea G; Meneses M; Torrelo A
    Pediatr Dermatol; 2021 Jan; 38(1):226-228. PubMed ID: 33155718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile hemangioma. Part 2: Management.
    Sebaratnam DF; Rodríguez Bandera AL; Wong LF; Wargon O
    J Am Acad Dermatol; 2021 Dec; 85(6):1395-1404. PubMed ID: 34419523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Perspectives: Propranolol for infantile hemangiomas.
    Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
    [No Abstract]   [Full Text] [Related]  

  • 18. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
    Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol Therapy for Problematic Infantile Hemangioma.
    Ng M; Knuth C; Weisbrod C; Murthy A
    Ann Plast Surg; 2016 Mar; 76(3):306-10. PubMed ID: 26010350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
    Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
    Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.